Exela Pharma Sciences is recalling an additional 14 lots of Sodium Bicarbonate Injection, USP, 8.4%, 50mEq/50 mL vial, 20-count carton. In total, the Company is recalling 63 lots of the product ...

Pfizer subsidiary Hospira issued a nationwide recall of its vials used to inject sodium bicarbonate, citing sterility concerns. The recall exacerbates the current shortage of the potentially ...

The recall pertains to lots of sodium bicarbonate 7.5% and 8.4% injection in 50-mL single-dose vials, as listed in the following tables. Sodium Bicarbonate Injection, USP, 7.5%, 44.6 mEq/50 mL ...

Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL Vial, 20-Count Carton Due to Vial Breakage Oct. 12, 2022 ...

Citing sterility concerns, Hospira, a subsidiary of pharma giant Pfizer, is voluntarily recalling vials used to inject sodium bicarbonate during surgery and in critical events. The nationwide ...

PLEASE NOTE: This recall, initiated on December 23, 2010 to the User or Consumer Level is for ALL unexpired lots of Sodium Bicarbonate Injection, USP, 7.5% and 8.4%, 50 mL Single Dose Vials.

Pfizer and the other sodium bicarbonate manufacturer, Amphastar Pharmaceuticals, expect to restock the syringes and vials by mid-August, according to the American Society of Health-System Pharmacists.

American Regent has initiated a nationwide voluntary recall of all unexpired lots of 50-mL single-dose vials of Sodium Bicarbonate Injection, USP, 7.5% and 8.4% because of the presence of ...